Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome
| Autor: | Lynd, Larry D., Najafzadeh, Mehdi, Colley, Lindsey, Byrne, Michael F., Willan, Andrew R., Sculpher, Mark J., Johnson, F. Reed, Hauber, A. Brett |
|---|---|
| Zdroj: | In Value in Health 2010 13(4):411-417 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect